UBS (Lux) Fund Solutions SICAV - UBS Solactive China Technology UCITS ETF hEUR acc- Capitalisation
No trades
Key stats
About UBS (Lux) Fund Solutions SICAV - UBS Solactive China Technology UCITS ETF hEUR acc- Capitalisation
Home page
Inception date
Mar 5, 2021
Structure
Luxembourg SICAV
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
UBS Asset Management (Europe) SA
ISIN
LU2265794946
The UBS Solactive China Technology UCITS ETF sub-fund is passively managed and will take proportionate exposure on the components of the Solactive China Technology (Net Return)
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Technology Services
Health Technology
Electronic Technology
Producer Manufacturing
Retail Trade
Stocks100.08%
Technology Services36.99%
Health Technology16.20%
Electronic Technology16.00%
Producer Manufacturing11.83%
Retail Trade10.36%
Consumer Durables7.34%
Communications1.26%
Health Services0.01%
Bonds, Cash & Other−0.08%
Cash−0.08%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
CITE invests in stocks. The fund's major sectors are Technology Services, with 37.02% stocks, and Health Technology, with 16.21% of the basket. The assets are mostly located in the Asia region.
CITE top holdings are Tencent Holdings Ltd and Alibaba Group Holding Limited, occupying 10.77% and 10.37% of the portfolio correspondingly.
CITE assets under management is 42.56 M EUR. It's risen 31.57% over the last month.
CITE fund flows account for 29.74 M EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, CITE doesn't pay dividends to its holders.
CITE shares are issued by UBS Group AG under the brand UBS. The ETF was launched on Mar 5, 2021, and its management style is Passive.
CITE expense ratio is 0.50% meaning you'd have to pay 0.50% of your investment to help manage the fund.
CITE follows the Solactive China Technology Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
CITE invests in stocks.
CITE price has risen by 6.80% over the last month, and its yearly performance shows a 81.74% increase. See more dynamics on CITE price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 2.44% over the last month, showed a 14.03% increase in three-month performance and has increased by 77.56% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 2.44% over the last month, showed a 14.03% increase in three-month performance and has increased by 77.56% in a year.
CITE trades at a premium (0.91%) meaning the ETF is trading at a higher price than the calculated NAV.